Targeted Biomarketing: Helping Biotech Businesses Grow

Eric DeRitis;

Publication

Article

May 15, 2002

BioPharm International

BioPharm International-06-01-2002

Volume15

Issue 6

Targeted Biomarketing: Helping Biotech Businesses Grow

Author(s):

Eric DeRitis

by Eric DeRitis, Real PR Network Communicating presents an image of openness, engendering trust; when you don't communicate, people soon think the worst. Biopharmaceutical companies frequently ignore corporate marketing until too late in the game: Public relations should start at inception to help companies start out correctly.

To view a PDF of this article from the BioPharm International archives, click this link

Articles in this issue

Negotiating and Structuring Strategic Alliances

Finding Funding in Biotechnology: Keeping the Companies Alive

Biotechnology Patent Holders Beware! A Supreme Court Ruling may Significantly Reduce the Value of Your Patent Portfolio

Guest Editorial: Enabling Collaboration in the Pharmaceutical Industry

Stem Cells and Xenotransplantation: Ethics, Patents, and Politics

Unlocking the Value of R&D: Managing the Risks

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!

Targeted Biomarketing: Helping Biotech Businesses Grow

Newsletter